Doximity Cash on Hand 2020-2025 | DOCS
Doximity cash on hand from 2020 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Doximity cash on hand for the quarter ending March 31, 2025 was $0.916B, a 20.02% increase year-over-year.
- Doximity cash on hand for 2025 was $0.916B, a 20.02% increase from 2024.
- Doximity cash on hand for 2024 was $0.763B, a 9.29% decline from 2023.
- Doximity cash on hand for 2023 was $0.841B, a 5.37% increase from 2022.
| Doximity Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2025 | $916 |
| 2024 | $763 |
| 2023 | $841 |
| 2022 | $798 |
| 2021 | $143 |
| 2020 | $86 |
| 2019 | $0 |
| Doximity Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-03-31 | $916 |
| 2024-12-31 | $845 |
| 2024-09-30 | $806 |
| 2024-06-30 | $750 |
| 2024-03-31 | $763 |
| 2023-12-31 | $710 |
| 2023-09-30 | $730 |
| 2023-06-30 | $873 |
| 2023-03-31 | $841 |
| 2022-12-31 | $801 |
| 2022-09-30 | $750 |
| 2022-06-30 | $776 |
| 2022-03-31 | $798 |
| 2021-12-31 | $766 |
| 2021-09-30 | $743 |
| 2021-06-30 | $726 |
| 2021-03-31 | $143 |
| 2020-12-31 | $143 |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | $86 |
| 2019-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $11.457B | $0.570B |
| Doximity Inc. provides digital platform for medical professionals. The company's network members include physicians across all specialties and practice areas. It provide its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and conduct virtual patient visits. Doximity Inc. is based in SAN FRANCISCO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.738B | 59.46 |
| Hims & Hers Health (HIMS) | United States | $12.987B | 134.93 |
| Tempus AI (TEM) | United States | $11.228B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.298B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.880B | 60.62 |
| Hinge Health (HNGE) | United States | $3.671B | 0.00 |
| Privia Health (PRVA) | United States | $2.475B | 169.17 |
| Clover Health Investments (CLOV) | United States | $1.735B | 0.00 |
| Schrodinger (SDGR) | United States | $1.690B | 0.00 |
| 10x Genomics (TXG) | United States | $1.677B | 0.00 |
| Phreesia (PHR) | United States | $1.648B | 0.00 |
| Enovis (ENOV) | United States | $1.582B | 8.82 |
| Azenta (AZTA) | United States | $1.578B | 73.36 |
| Omnicell (OMCL) | United States | $1.321B | 23.31 |
| Evolent Health (EVH) | United States | $1.199B | 102.10 |
| Claritev (CTEV) | United States | $0.719B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.575B | 0.00 |
| Standard BioTools (LAB) | United States | $0.551B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.532B | 0.00 |
| Veradigm (MDRX) | United States | $0.503B | 0.00 |
| Talkspace (TALK) | United States | $0.438B | 131.00 |
| TruBridge (TBRG) | United States | $0.347B | 770.33 |
| Outset Medical (OM) | United States | $0.345B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.282B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.265B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.241B | 0.00 |
| CapsoVision (CV) | United States | $0.197B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.176B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.164B | 0.00 |
| Pulmonx (LUNG) | United States | $0.152B | 0.00 |
| American Well (AMWL) | United States | $0.134B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.122B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.115B | 0.00 |
| CareCloud (CCLD) | United States | $0.105B | 3.98 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.086B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.083B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |